Fernando Lopitz Otsoa

Liver Disease Lab/Liver Metabolism Lab

CIC bioGUNE. Center for Cooperative Research in Biosciences

Fernando Lopitz-Otsoa
PhD. Permanent staff.

Fernando Lopitz Otsoa joined CIC bioGUNE in 2006 and the Liver disease lab/Liver metabolism Lab in 2012. He obtained his PhD in 2004 from the University of the Basque Country (UPV/EHU) funded by this same institution. During this period, his research was focused on the antibiotic resistance mechanisms. During those years he developed part of his Thesis work at the Department of Microbiology & Public Health Laboratory at Queen's Medical Centre in Nottingham (UK). After this period, his post-doctoral studies involved molecular method and reagent development for the detection of foodborne pathogens at the Faculty of Pharmacy at the UPV/EHU and afterwards his research interests led him to work on post-translational modifications and more precisely ubiquitination, sumoylation and needylation (2006-2012) in the Proteomics Unit of CIC bioGUNE. At present, he is part of the permanent staff of CIC bioGUNE and part of his work focuses on the study of post-translational modifications in proteins involved in liver diseases and metabolism. He has a longstanding interest in ubiquitin and ubiquitin-like molecules and their roles in physiology and disease. He has coauthored more than 30 papers in the last 10 years and has reviewed papers for several journals of his research area.

https://www.researchgate.net/profile/Fernando_Lopitz-Otsoa

Publications

SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

1Liver Disease and Liver Metabolism Lab, CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 2Proteomics Platforms, CIC bioGUNE, ProteoRED-ISCIII, CIBERehd, 3Advanced Technology Institute in Life Sciences (ITAV)-CNRS-IPBS, UbiCARE

JoVE 60098

 Biochemistry